Clinical Trial Update: GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection [Phase 2]

View source ↗

Summary

Phase 2 randomized trial comparing GSK1322322 to Linezolid for acute bacterial skin and skin structure infections has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin and Skin Structure Infection

Drugs mentioned

• GSK1322322
• Linezolid (Linezolid)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Skin Infections, Bacterial | Phase 2 | Status: COMPLETED | Results posted: 2017-12-04